Gemcitabine Hcl

Gemcitabine Hcl（CAS 122111-03-9）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

这个物质在各数据库里的编号

数据库记载的用途

• Gemcitabine hydrochloride is approved to be used alone or with other drugs to treat:
• • Breast cancer that cannot be treated with or that did not respond to chemotherapy that included an anthracycline drug. It is used with paclitaxel as the first therapy for cancer that has spread to other parts of the body.
• • Non-small cell lung cancer. It is used with cisplatin in patients whose cancer is stage IIIA, stage IIIB, or stage IV.
• • Ovarian cancer that is advanced and has relapsed at least 6 months after treatment with platinum chemotherapy. It is used with carboplatin.
• • Pancreatic cancer. It is used alone in patients whose cancer is stage II or stage III and cannot be removed by surgery or stage IV. It is used in patients whose cancer has been treated with fluorouracil.
• Gemcitabine hydrochloride is also being studied in the treatment of other types of cancer.

它在各数据库里的别名

GEMCITABINE HYDROCHLORIDE; 122111-03-9; Gemcitabine HCl; LY188011 hydrochloride; 2'-Deoxy-2',2'-difluorocytidine monohydrochloride; 2'-deoxy-2',2'-difluorocytidine hydrochloride; INFUGEM; Gemcitabine (as hydrochloride); Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochloride; DTXSID3047849; Gemcitabine HCI; U347PV74IL; LY-188011 HYDROCHLORIDE; 2',2'-Difluorodeoxycytidine monohydrochloride; DTXCID3027827; NSC613327

计算机算出的分子描述符

数据库摘要

Gemcitabine Hcl · CAS 122111-03-9 · C9H12ClF2N3O4. UNII U347PV74IL.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。